BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37551496)

  • 1. [Effect of Plasmacytoid Dendritic Cell Dose in Grafts on CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation].
    Yao D; Tian YY; Lu J; Xiao PF; Ling J; Zheng DF; Gao J; Fan LY; Zheng JJ; Li J; Hu SY
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Aug; 31(4):1184-1191. PubMed ID: 37551496
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patients with refractory cytomegalovirus (CMV) infection following allogeneic haematopoietic stem cell transplantation are at high risk for CMV disease and non-relapse mortality.
    Liu J; Kong J; Chang YJ; Chen H; Chen YH; Han W; Wang Y; Yan CH; Wang JZ; Wang FR; Chen Y; Zhang XH; Xu LP; Liu KY; Huang XJ
    Clin Microbiol Infect; 2015 Dec; 21(12):1121.e9-15. PubMed ID: 26093077
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A Low Level of Plasmacytoid Dendritic Cells at Engraftment Is a Valuable Prognostic Indicator in Children Receiving Allogeneic Hematopoietic Stem Cell Transplantation.
    Li B; Meng L; Tian Y; Ling J; Hu Y; Lu Q; Gao L; Wu S; Zhang Y; Hu S
    Transplant Cell Ther; 2021 Jul; 27(7):611.e1-611.e12. PubMed ID: 33895404
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Cytomegalovirus infection monitoring in patients with long-term survival after allogeneic hematopoietic stem cell transplantation].
    Chen L; Luo Y; Hu Y; Tan Y; Zhao Y; Fan J; Huang H
    Zhonghua Yi Xue Za Zhi; 2014 Nov; 94(40):3145-9. PubMed ID: 25573309
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Clinical Study of Cytomegalovirus Infection after Allogeneic Hematopoietic Stem Cell Transplantation].
    Xiong YY; Liu L; Chen JB; Tang XQ; Xiao Q; Zhang HB; Wang L
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2023 Apr; 31(2):513-521. PubMed ID: 37096528
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Cytomegalovirus diseases after allogeneic hematopoietic stem cell transplantation (Allo-HSCT) and related risk factors].
    Huang XJ; Xu LP; Ren HY; Zhang YC; Guo NL; Lu DP
    Zhonghua Yi Xue Za Zhi; 2003 May; 83(9):766-9. PubMed ID: 12899755
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Features of cytomegalovirus infection and evaluation of cytomegalovirus-specific T cells therapy in children's patients following allogeneic hematopoietic stem cell transplantation: A retrospective single-center study.
    Ruan Y; Luo T; Liu Q; Liu X; Chen L; Wen J; Xiao Y; Xie D; He Y; Wu X; Feng X
    Front Cell Infect Microbiol; 2022; 12():1027341. PubMed ID: 36339340
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Clinical Analysis of Cytomegalovirus Infection after Different Patterns of Hematopoietic Stem Cell Transplantation].
    Wang S; Liu DB; Zheng XL; Ding L; Han DM; Wang ZD; Yan HM; Wang HX
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2015 Oct; 23(5):1438-44. PubMed ID: 26524053
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Risk-factor analysis of poor graft function after allogeneic hematopoietic stem cell transplantation.
    Xiao Y; Song J; Jiang Z; Li Y; Gao Y; Xu W; Lu Z; Wang Y; Xiao H
    Int J Med Sci; 2014; 11(6):652-7. PubMed ID: 24834012
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytomegalovirus Reactivation after Allogeneic Hematopoietic Stem Cell Transplantation is Associated with a Reduced Risk of Relapse in Patients with Acute Myeloid Leukemia Who Survived to Day 100 after Transplantation: The Japan Society for Hematopoietic Cell Transplantation Transplantation-related Complication Working Group.
    Takenaka K; Nishida T; Asano-Mori Y; Oshima K; Ohashi K; Mori T; Kanamori H; Miyamura K; Kato C; Kobayashi N; Uchida N; Nakamae H; Ichinohe T; Morishima Y; Suzuki R; Yamaguchi T; Fukuda T
    Biol Blood Marrow Transplant; 2015 Nov; 21(11):2008-16. PubMed ID: 26211985
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Enumeration of bone marrow plasmacytoid dendritic cells by multiparameter flow cytometry as a prognostic marker following allogeneic hematopoietic stem cell transplantation.
    Su RJ; Green R; Chen M
    Blood Cells Mol Dis; 2018 Mar; 69():107-112. PubMed ID: 29137845
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A clinical study of lyophilized intravenous human immunoglobulin containing high-titer cytomegalovirus-neutralizing antibody for the treatment of cytomegalovirus viremia after allogeneic hematopoietic stem cell transplantation.
    Zhang P; Yang D; Tian J; Feng S; Jiang E; Han M
    Ann Palliat Med; 2021 May; 10(5):5533-5540. PubMed ID: 34107701
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Clinical study of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    He J; Chen BA; Ni M; Wu X; Ding JH
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2014 Oct; 22(5):1371-6. PubMed ID: 25338591
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HLA-DRB1*09 is associated with increased incidence of cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation.
    Du J; Liu J; Gu J; Zhu P
    Biol Blood Marrow Transplant; 2007 Dec; 13(12):1417-21. PubMed ID: 18022570
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cytomegalovirus infection and disease after allogeneic hematopoietic stem cell transplantation: experience in a center with a high seroprevalence of both CMV and hepatitis B virus.
    Liu YC; Lu PL; Hsiao HH; Chang CS; Liu TC; Yang WC; Lin SF
    Ann Hematol; 2012 Apr; 91(4):587-95. PubMed ID: 21997849
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Clinical Analysis of CMV Infection after Allogeneic Hematopoietic Stem Cell Transplantation in Severe Aplastic Anemia].
    Wang LL; Mo WJ; Zhang YP; Chen XW; Wang CX; Zhou M; Wang SQ
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2021 Jun; 29(3):944-950. PubMed ID: 34105498
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cecum ulcer is a reliable endoscopic finding in cytomegalovirus colitis concomitant with graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
    Matsuda K; Ono S; Ishikawa M; Miyamoto S; Abiko S; Tsuda M; Yamamoto K; Kudo T; Shimizu Y; Hayase E; Hashimoto D; Teshima T; Matsuno Y; Sakamoto N
    Ann Hematol; 2018 May; 97(5):877-883. PubMed ID: 29340759
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Analysis of risk factors and prognosis of cytomegalovirus infection post umbilical cord blood stem cell transplantation in children with primary immunodeficiency diseases].
    Wei ZL; Qian XW; Wang P; Jiang WJ; Wang HS; Shen C; Wang WJ; Hou J; Wang YH; Huang Y; Wang XC; Zhai XW
    Zhonghua Er Ke Za Zhi; 2022 Oct; 60(10):1019-1025. PubMed ID: 36207848
    [No Abstract]   [Full Text] [Related]  

  • 19. Cytomegalovirus infection and rehospitalization rates after allogeneic hematopoietic stem cell and solid organ transplantation: a retrospective cohort study using German claims data.
    Teschner D; Knop J; Piehl C; Junker S; Witzke O
    Infection; 2022 Dec; 50(6):1543-1555. PubMed ID: 35633464
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Clinical analysis of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation].
    Guo Z; Chen HR; Liu XD; Bian JM; He XP; Lou JX; Chen P; Yang K; Liu D; Zhang Y
    Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2012 Aug; 20(4):971-4. PubMed ID: 22931666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.